首页> 外文期刊>Journal of drug delivery science and technology >Microporous polycaprolactone matrices for drug delivery and tissue engineering: The release behaviour of bioactives having extremes of aqueous solubility
【24h】

Microporous polycaprolactone matrices for drug delivery and tissue engineering: The release behaviour of bioactives having extremes of aqueous solubility

机译:用于药物递送和组织工程的微孔聚己内酯基质:具有极端水溶性的生物释放的释放行为

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Microporous polycaprolactone (PCL) matrices loaded with hydrophobic steroidal drugs or a hydrophilic drug - pilocarpine hydrochloride - were produced by precipitation casting using solutions of PCL in acetone. The efficiency of steroid incorporation in the final matrix (progesterone (56 %) testosterone (46 %) dexamethasone (80 %)) depended on the nature of the drug initially co-dissolved in the PCL solution. Approximately 90 % w/w of the initial load of progesterone, 85 % testosterone and 50 % dexamethasone was released from the matrices in PBS at 37°C over 8 days. Pilocarpine hydrochloride (PH)-loaded PCL matrices, prepared by dispersion of powder in PCL solution, released 70-90 % of the PH content over 12 days in PBS. Application of the Higuchi model revealed that the kinetics of steroid and PH release were consistent with a Fickian diffusion mechanism with corresponding diffusion coefficients of 5.8 × 10 -9 (progesterone), 3.9 × 10 -9 (testosterone), 7.1 × 10 -10 (dexamethasone) and 22 × 10 -8 cm 2/s (pilocarpine hydrochloride). The formulation techniques described are expected to be useful for production of implantable, insertable and topical devices for sustained delivery of a range of bioactive molecules of interest in drug delivery and tissue engineering.
机译:通过使用PCL溶液在丙酮中使用PCL溶液,通过沉淀浇铸制备的微孔聚己内酯(PCL)盐酸盐 - 盐酸盐盐酸盐(PCL)盐酸盐。在最终基质中的类固醇掺入(孕酮(56%)睾酮(46%)的地塞米松(80%))依赖于最初共溶于PCL溶液中的药物的性质。大约90%w / w的初始载体,85%睾酮和50%地塞米松在37℃下在8天内从PBS的基质中释放出来。通过在PCL溶液中分散在PCL溶液中粉末制备的盐酸纤维甘油(pH)加载的PCL基质,在PBS中释放了70-90%的pH值超过12天。 HIGUCHI模型的应用表明,类固醇和pH释放的动力学与具有5.8×10 -9(孕酮),3.9×10 -9(睾丸激素),7.1×10 -10(地塞米松)和22×10 -8 cm 2 / s(硫甘薯盐酸盐)。所描述的配方技术预计可用于生产可植入,可插入和局部装置,用于持续递送一系列吸毒和组织工程的生物活性分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号